BELGIUM – In a bid to allay EU antitrust concerns about its proposed takeover of cancer detection test maker Grail, Illumina has offered to cut prices and continue to allow…
Read MoreIllumina moves to dispel EU antitrust concerns over US$8 billion Grail deal
